Is elimination of HCV realistic by 2030: France von Pol, Stanislas, Lair‐Mehiri, Loriane, Vallet‐Pichard, Anaïs, Aghemo, Alessio

Volltext

Long‐term follow‐up of diabetic and non‐diabetic patients with chronic hepatitis C von Ciancio, Alessia, Ribaldone, Davide Giuseppe, Sacco, Marco, Saracco, Giorgio Maria, Aghemo, Alessio

Volltext

Aminopyrine breath test predicts liver‐related events and death in HCV‐related cirrhosis on SVR after DAA therapy von Petta, Salvatore, Rini, Francesca, Calvaruso, Vincenza, Cammà, Calogero, Ciminnisi, Stefania, Di Marco, Vito, Giannini, Edoardo G., Grimaudo, Stefania, Maria Pipitone, Rosaria, Craxì, Antonio, Aghemo, Alessio

Volltext

EASL recommendations on treatment of hepatitis C: Final update of the series von Pawlotsky, Jean-Michel, Negro, Francesco, Aghemo, Alessio, Berenguer, Marina, Dalgard, Olav, Dusheiko, Geoffrey, Marra, Fiona, Puoti, Massimo, Wedemeyer, Heiner

Volltext

Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19” von Iavarone, Massimo, D'Ambrosio, Roberta, Lampertico, Pietro, Iavarone, M., D’Ambrosio, R., Rimondi, A., Lampertico, P., Soria, A., Bonfanti, P., Triolo, M., Fagiuoli, S., Pugliese, N., Aghemo, A., Del Poggio, P., Perricone, G., Belli, L.S., Massironi, S., Lucà, M., Invernizzi, P., Spinetti, A., Carriero, C., Buscarini, E., Pedaci, M., Viganò, M., Rumi, M.G.

Volltext

EASL Recommendations on Treatment of Hepatitis C 2018 von Pawlotsky, Jean-Michel, Negro, Francesco, Aghemo, Alessio, Berenguer, Marina, Dalgard, Olav, Dusheiko, Geoffrey, Marra, Fiona, Puoti, Massimo, Wedemeyer, Heiner

Volltext

EASL Recommendations on Treatment of Hepatitis C 2015 von European Association for the Study of the Liver, European Association for Study of Liver

Volltext

Liver stiffness measurement reliability and main determinants of point shear‐wave elastography in patients with chronic liver disease von Fraquelli, M., Baccarin, A., Casazza, G., Conti, C. B., Giunta, M., Massironi, S., Invernizzi, F., Donato, M. F., Maggioni, M., Aghemo, A., Conte, D., Colombo, M.

Volltext

EASL Clinical Practice Guidelines: Management of hepatitis C virus infection von European Association for the Study of the Liver, European Association for Study of Liver

Volltext

High efficacy of direct‐acting anti‐viral agents in hepatitis C virus‐infected cirrhotic patients with successfully treated hepatocellular carcinoma von Persico, M., Aglitti, A., Aghemo, A., Rendina, M., Lleo, A., Ciancio, A., Di Marco, V., Lampertico, P., Brunetto, M. R., Zuin, M., Andreone, P., Villa, E., Troshina, G., Calvaruso, V., Degasperi, E., Coco, B., Giorgini, A., Conti, F., Di Leo, A., Marzi, L., Boccaccio, V., Bollani, S., Maisonneuve, P., Bruno, S.

Volltext

Commentary: absolute and relative contraindications to pegylated‐interferon or ribavirin in the US general patient population with chronic hepatitis C von Aghemo, A., Lampertico, P.

Volltext

Feasibility and reproducibility of spleen transient elastography and its role in combination with liver transient elastography for predicting the severity of chronic viral hepatiti... von Fraquelli, M., Giunta, M., Pozzi, R., Rigamonti, C., Della Valle, S., Massironi, S., Conti, C. B., Aghemo, A., Ronchi, G., Iurlo, A., Primignani, M., Conte, D., Colombo, M.

Volltext

EASL Recommendations on Treatment of Hepatitis C 2014 von European Association for the Study of the Liver

Volltext

Estimating HCV disease burden - volume 3 (editorial) von Aghemo, A., Dore, G. J., Hatzakis, A., Wedemeyer, H., Razavi, H.

Volltext

Clinical drivers in naïve patient eligibility for treatment of chronic hepatitis C von Degasperi, E., Aghemo, A.

Volltext

Cirrhosis regression does not prevent hepatocellular carcinoma in patients with a sustained virological response to IFN von D’ambrosio, R, Aghemo, A, Degasperi, E, Sangiovanni, A, Rumi, M, Fraquelli, M, Perbellini, R, Bedossa, P, Colombo, M, Lampertico, P

Volltext

TM6SF2, MBOAT7 and PNPLA3 genotypes in patients with untreated HCV chronic hepatitis and alcohol intake von Degasperi, E, Aghemo, A, Galmozzi, E, D’Ambrosio, R, De Nicola, S, Colombo, M, Lampertico, P

Volltext

High-resolution melting assay for genotyping of IFNL4-associated dinucleotide variant rs368234815 von Galmozzi, E., Facchetti, F., Perbellini, R., Aghemo, A.

Volltext

Inosine triphosphatase deficiency helps predict anaemia, anaemia management and response in chronic hepatitis C therapy von Clark, P. J., Aghemo, A., Degasperi, E., Galmozzi, E., Urban, T. J., Vock, D. M., Patel, K., Thompson, A. J., Rumi, M. G., D'Ambrosio, R., Muir, A. J., Colombo, M.

Volltext

TM6SF2 and MBOAT7 genotype to determine alcohol-related liver damage in patients with HCV chronic hepatitis von Degasperi, E, Aghemo, A, Galmozzi, E, D’Ambrosio, R, De Nicola, S, Colombo, M

Volltext